Novartis CEO Joins AI Firm Anthropic's Board, Signaling Pharma's Tech Pivot
Vasant Narasimhan, CEO of Swiss pharma giant Novartis, has been appointed to the board of AI company Anthropic. The move signals a strategic deepening of the ties between the pharmaceutical industry and the world of artificial intelligence, with major implications for future drug development.








